SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-015976
Filing Date
2022-03-03
Accepted
2022-03-03 20:03:53
Documents
2
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12157
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3985
  Complete submission text file 0001209191-22-015976.txt   17554
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE MA 02139
Business Address
Sepp-Lorenzino Laura (Reporting) CIK: 0001777421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 22711545